Complete guide to oral semaglutide — Rybelsus (FDA-approved for T2D), OASIS Phase 3 data (~15.1% weight loss at 50 mg), SNAC absorption mechanism, Rybelsus vs Ozempic comparison, and the oral obesity NDA timeline.